National Health Research Institutes, Taiwan
Clinical trials sponsored by National Health Research Institutes, Taiwan, explained in plain language.
-
Double Immune-Boosting combo enters trial for Tough-to-Treat bile duct cancer
Disease control Not yet recruitingThis study is testing if adding a second immunotherapy drug (relatlimab) to a standard treatment improves outcomes for people with advanced bile duct cancer. About 76 patients who haven't had prior treatment for their advanced cancer will be randomly assigned to receive either th…
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Apr 03, 2026 14:52 UTC
-
New hope for liver cancer patients when first treatment fails
Disease control Not yet recruitingThis study is testing the drug cabozantinib for people with advanced liver cancer (hepatocellular carcinoma) whose disease has gotten worse after standard first-line immunotherapy combinations. The main goals are to see if the drug can control the cancer for at least 6 months and…
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
Can online therapy ease anxiety and depression from home?
Symptom relief Not yet recruitingThis study is testing whether an 8-week online therapy program can help reduce symptoms of anxiety and depression in adults. Participants will be randomly assigned to receive either their usual care alone or their usual care plus the online program. The goal is to see if this con…
Phase: NA • Sponsor: National Health Research Institutes, Taiwan • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC